These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17430861)

  • 1. Progressive supranuclear palsy.
    Warren NM; Burn DJ
    Pract Neurol; 2007 Feb; 7(1):16-23. PubMed ID: 17430861
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal cytological changes of progressive supranuclear palsy type in clinically possible progressive supranuclear palsy.
    Toru S; Uchihara T; Akashi T; Kobayashi T
    Eur Neurol; 2010; 63(2):122-5. PubMed ID: 20110714
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene.
    Rossi G; Gasparoli E; Pasquali C; Di Fede G; Testa D; Albanese A; Bracco F; Tagliavini F
    Ann Neurol; 2004 Mar; 55(3):448. PubMed ID: 14991829
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient page. Progressive supranuclear palsy.
    Karceski S
    Neurology; 2008 Nov; 71(22):e70-2. PubMed ID: 19029512
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can mid-sagittal MRI be used to diagnose progressive supranuclear palsy?
    Reich SG
    Nat Clin Pract Neurol; 2006 Jan; 2(1):12-3. PubMed ID: 16932511
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive supranuclear gaze palsy without parkinsonism: a case of neuro-Whipple.
    Magherini A; Pentore R; Grandi M; Leone ME; Nichelli PF
    Parkinsonism Relat Disord; 2007 Oct; 13(7):449-52. PubMed ID: 17071126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy.
    Oliva R; Pastor P
    Ann Neurol; 2004 Mar; 55(3):448-9. PubMed ID: 14991828
    [No Abstract]   [Full Text] [Related]  

  • 12. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and progressive supranuclear palsy: is everything so clear?
    Sibon I; Macia F; Vital A; Delacourte A; Tison F
    Mov Disord; 2004 Oct; 19(10):1259-61. PubMed ID: 15390036
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progressive supranuclear palsy].
    Miyazaki M; Amano N
    Ryoikibetsu Shokogun Shirizu; 2003; (40):265-8. PubMed ID: 14626116
    [No Abstract]   [Full Text] [Related]  

  • 15. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tau of PSP: a long road to treatment.
    Golbe LI
    Mov Disord; 2014 Apr; 29(4):431-4. PubMed ID: 24585428
    [No Abstract]   [Full Text] [Related]  

  • 17. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy.
    Gröschel K; Kastrup A; Litvan I; Schulz JB
    Neurology; 2006 Mar; 66(6):949-50. PubMed ID: 16567726
    [No Abstract]   [Full Text] [Related]  

  • 18. Teaching NeuroImages: "Penguin" or "hummingbird" sign and midbrain atrophy in progressive supranuclear palsy.
    Graber JJ; Staudinger R
    Neurology; 2009 Apr; 72(17):e81. PubMed ID: 19398699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interobserver bias in detecting the penguin-silhouette sign].
    Romero JO
    Neurologia; 2007 Oct; 22(8):557-8. PubMed ID: 18000766
    [No Abstract]   [Full Text] [Related]  

  • 20. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
    Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.